DNA Vaccine Market, Status and Forecast, by Players, Types and Applications
Factors responsible for the growth of the industry are rise in adoption of personalized medicine applications and DNA identification as a therapy. Rising influence of commercialization and digitalization in healthcare sector are driving the demand for DNA vaccine, in the recent years.
Factors responsible for the growth of the industry are rise in adoption of personalized medicine applications and DNA identification as a therapy. Rising influence of commercialization and digitalization in healthcare sector are driving the demand for DNA vaccine, in the recent years.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>DNA</strong> <strong>Vaccine</strong> <strong>Market</strong> 2025 <strong>by</strong> Share, Trends, Supply,<br />
Sales <strong>and</strong> Key <strong>Players</strong> Analysis<br />
“<strong>DNA</strong> <strong>Vaccine</strong> <strong>Market</strong> Research Report identifies<br />
Key Trends, Drivers, <strong>Applications</strong>, Opportunities <strong>and</strong><br />
Challenges in the market. This industry research<br />
report also presents a detailed analysis of the<br />
market <strong>by</strong> Type, Size, Sales <strong>and</strong> Revenue <strong>by</strong><br />
geography.”<br />
27 February, 2019: The Global <strong>DNA</strong> <strong>Vaccine</strong> <strong>Market</strong> size is expected to display higher growth rate over the next seven<br />
years. The market is subject to witness a substantial growth due to the high-end dem<strong>and</strong> for effective <strong>and</strong> low cost<br />
vaccines. Growing prevalence of infectious diseases, ever-increasing geriatric population, rising vulnerability towards<br />
genetic diseases <strong>and</strong> rising number of resistant pathogens are expected to drive market dem<strong>and</strong> for <strong>DNA</strong> vaccines in the<br />
upcoming years.<br />
Additionally, higher approval rate <strong>by</strong> local & international organization in veterinary sector owing to the proven long<br />
lasting results of <strong>DNA</strong> vaccines <strong>and</strong> higher performance in comparison with the traditional vaccines are likely positively<br />
affect market growth. Globally, the market is predicted to generate massive revenue over the next seven years, providing<br />
numerous opportunities for market players to invest for research <strong>and</strong> development in the <strong>DNA</strong> vaccine market.<br />
Browse Full Research Report @ https://www.millioninsights.com/industry-reports/dna-vaccine-market-insights<br />
Factors responsible for the growth of the industry are rise in adoption of personalized medicine applications <strong>and</strong> <strong>DNA</strong><br />
identification as a therapy. The personalised medicine application helps in the treatment of number of chronic diseases,
thus driving the need for HLA typing for therapies. Furthermore, recent technological advancement <strong>and</strong> increasing<br />
adoption of digital services in healthcare sector is leads in increase of commercialization for next generation diagnostics,<br />
which is expected to fuel market dem<strong>and</strong> for <strong>DNA</strong> vaccine over the forecast period. Rising influence of<br />
commercialization <strong>and</strong> digitalization in healthcare sector are driving the dem<strong>and</strong> for <strong>DNA</strong> vaccine, in the recent years.<br />
<strong>DNA</strong> vaccine helps to protect against disease with the help of genetically engineered <strong>DNA</strong> that are capable of producing<br />
various antigens <strong>and</strong> protective immunological response in the human <strong>and</strong> animal’s body. <strong>DNA</strong> vaccines offers<br />
numerous advantages over the conventional vaccines due to their wider range of immune response types. These factors<br />
are expected to pave the way for future market growth of <strong>DNA</strong> vaccines. Increasing dem<strong>and</strong> for <strong>DNA</strong> vaccines for<br />
veterinary use is projected to foster market growth over the forecast period.<br />
Current <strong>DNA</strong> vaccines are referred as third generation vaccines as they consist of <strong>DNA</strong> that codes for specific proteins<br />
or antigens from a given pathogen. These <strong>DNA</strong> are injected into the animal or human body, which is then taken up <strong>by</strong><br />
cells. Such cells undergo normal metabolic processes <strong>and</strong> synthesize proteins based on the genetic code in the plasmid.<br />
This process triggers immune responses in the patient. These factors are propelling the dem<strong>and</strong> for <strong>DNA</strong> vaccines to<br />
boost immune response of the animal or human body.<br />
Get a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/dna-vaccine-marketinsights/request-sample<br />
The market is broadly categorized into two major segments based on the application type such as human <strong>DNA</strong> vaccines<br />
<strong>and</strong> animal <strong>DNA</strong> vaccines. The animal <strong>DNA</strong> vaccines is considered as one of the fastest growing segment in the <strong>DNA</strong><br />
vaccine market with substantial revenue generation in the last few years.<br />
Growing popularity of the animal <strong>DNA</strong> vaccines segment is attributed to the higher approval rate <strong>and</strong> current<br />
development in the field of <strong>DNA</strong> synthesis, immunology <strong>and</strong> molecular biology. The human <strong>DNA</strong> vaccines segment<br />
has also witnessed substantial growth due to increase in investment <strong>by</strong> private <strong>and</strong> government authorities in research<br />
& development activities across the globe.<br />
Asia-Pacific region is predicted to hold major market share in the <strong>DNA</strong> vaccine market with massive growth in forecast<br />
period. Countries such as India, China <strong>and</strong> Singapore are leading the Asia-Pacific market with strong economic growth<br />
in the region, ever-growing geriatric population, increasing healthcare expenditure, <strong>and</strong> significant investment <strong>by</strong><br />
leading industry players considering potential growth opportunities in the region.<br />
The key players in the <strong>DNA</strong> vaccine market are Arbutus Biopharma Co., Sanofi S.A., Vical Ltd., Astellas Pharma, Inc.,<br />
Dendreon Co., Merck & Co., Invio Biomedical, Inc., <strong>and</strong> Novartis Animal Health, Inc.<br />
Browse Full Research Report @ https://www.millioninsights.com/industry-reports/dna-vaccine-market-insights
Get in touch<br />
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction.<br />
Our representatives strive to underst<strong>and</strong> diverse client requirements <strong>and</strong> cater to the same with the<br />
most innovative <strong>and</strong> functional solutions.<br />
Contact Person:<br />
Ryan Manuel<br />
Research Support Specialist, USA<br />
Email: ryan@millioninsights.com<br />
Global Headquarters<br />
Million Insights<br />
Felton Office Plaza 6265 Highway 9<br />
Felton, California 95018, United States<br />
Phone: 1-408-610-2300<br />
Email: sales@millioninsights.com<br />
Asia Pacific<br />
Million Insights<br />
Office No. 302, 3rd Floor, Manikch<strong>and</strong><br />
Galleria, Model Colony, Shivaji Nagar,<br />
Pune, MH, 411016 India<br />
Phone: 91-20-65300184<br />
Email: sales@millioninsights.com<br />
Visit Our Blog:<br />
www.millioninsights.blogspot.com
Change language